Combined Mitral and Tricuspid Versus Isolated Mitral Transcatheter Edge-to-Edge Repair for Mitral Regurgitation With Tricuspid Regurgitation (DUAL-TEER Trial)

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 404 participants.

Also called NCT07349888

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 404 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07349888
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07349888. Randomized; single masking; primary purpose treatment. Start 2026-02-01 (anticipated); primary completion 2031-02-28 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Combined Mitral and Tricuspid Versus Isolated Mitral Transcatheter Edge-to-Edge Repair for Mitral Regurgitation With Tricuspid Regurgitation (DUAL-TEER Trial)
Condition
Mitral Regurgitation
Condition
Tricuspid Regurgitation
Intervention (Device)
Transcatheter Edge-to-Edge Repair (TEER) System
Lead sponsor
Nanjing First Hospital, Nanjing Medical University (class: other)

Record details

Record id
cardio:ct-nct07349888
Content hash
a6242171cb0dc45803ad99959f571b89dde8843c83231687c6072d51431bb988